475 related articles for article (PubMed ID: 19434849)
41. Kinetic analysis of nonisothermal differential scanning calorimetry of 1,3-dipalmitoyl-2-oleoylglycerol.
Smith KW; Cain FW; Talbot G
J Agric Food Chem; 2005 Apr; 53(8):3031-40. PubMed ID: 15826056
[TBL] [Abstract][Full Text] [Related]
42. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
[TBL] [Abstract][Full Text] [Related]
43. Crystallization kinetics of amorphous griseofulvin by pattern fitting procedure using X-ray diffraction data.
Yamamura S; Takahira R; Momose Y
Pharm Res; 2007 May; 24(5):880-7. PubMed ID: 17372690
[TBL] [Abstract][Full Text] [Related]
44. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
[TBL] [Abstract][Full Text] [Related]
45. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
[TBL] [Abstract][Full Text] [Related]
46. Thermal insight of mechanically activated bile acid powders.
Ito T; Byrn S; Chen X; Carvajal MT
Int J Pharm; 2011 Nov; 420(1):68-75. PubMed ID: 21872650
[TBL] [Abstract][Full Text] [Related]
47. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.
Miyazaki T; Yoshioka S; Aso Y; Kawanishi T
Int J Pharm; 2007 May; 336(1):191-5. PubMed ID: 17184940
[TBL] [Abstract][Full Text] [Related]
48. Calorimetric evidence for two distinct molecular packing arrangements in stable glasses of indomethacin.
Kearns KL; Swallen SF; Ediger MD; Sun Y; Yu L
J Phys Chem B; 2009 Feb; 113(6):1579-86. PubMed ID: 19154147
[TBL] [Abstract][Full Text] [Related]
49. Assessing Physical Stability Risk Using the Amorphous Classification System (ACS) Based on Simple Thermal Analysis.
Zhou D; Schmitt EA; Law D; Brackemeyer PJ; Zhang GGZ
Mol Pharm; 2019 Jun; 16(6):2742-2754. PubMed ID: 31017794
[TBL] [Abstract][Full Text] [Related]
50. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
Moura Ramos JJ; Diogo HP
Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
[TBL] [Abstract][Full Text] [Related]
51. Assessment of milling-induced disorder of two pharmaceutical compounds.
Otte A; Carvajal MT
J Pharm Sci; 2011 May; 100(5):1793-804. PubMed ID: 21374615
[TBL] [Abstract][Full Text] [Related]
52. Thermal analysis of tertiary butyl alcohol/sucrose/water ternary system.
Zuo JG; Hua TC; Liu BL; Zhou GY
Cryo Letters; 2005; 26(5):289-96. PubMed ID: 19827244
[TBL] [Abstract][Full Text] [Related]
53. Solid-state vitrification of crystalline griseofulvin by mechanical milling.
Willart JF; Carpentier L; Danède F; Descamps M
J Pharm Sci; 2012 Apr; 101(4):1570-7. PubMed ID: 22252982
[TBL] [Abstract][Full Text] [Related]
54. Solvates of the antifungal drug griseofulvin: structural, thermochemical and conformational analysis.
Aitipamula S; Chow PS; Tan RB
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):54-62. PubMed ID: 24441128
[TBL] [Abstract][Full Text] [Related]
55. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
[TBL] [Abstract][Full Text] [Related]
56. Water-solid interactions. III. Effect of glass transition temperature, Tg, and processing on tensile strength of compacts of lactose and lactose/polyvinyl pyrrolidone.
Stubberud L; Arwidsson HG; Hjortsberg V; Graffner C
Pharm Dev Technol; 1996 Jul; 1(2):195-204. PubMed ID: 9552346
[TBL] [Abstract][Full Text] [Related]
57. Influence of low-temperature nucleation on the crystallization process of poly(L-lactide).
Hernández Sánchez F; Molina Mateo J; Romero Colomer FJ; Salmerón Sánchez M; Gómez Ribelles JL; Mano JF
Biomacromolecules; 2005; 6(6):3283-90. PubMed ID: 16283757
[TBL] [Abstract][Full Text] [Related]
58. A stable amorphous statin: solid-state NMR and dielectric studies on dynamic heterogeneity of simvastatin.
Nunes TG; Viciosa MT; Correia NT; Danède F; Nunes RG; Diogo HP
Mol Pharm; 2014 Mar; 11(3):727-37. PubMed ID: 24499472
[TBL] [Abstract][Full Text] [Related]
59. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
[TBL] [Abstract][Full Text] [Related]
60. Glass transition and the origin of poly(p-phenylene sulfide) secondary crystallization.
D'Ilario L; Martinelli A
Eur Phys J E Soft Matter; 2006 Jan; 19(1):37-45. PubMed ID: 16416246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
